Ora Inc.
Industry
- Contract Research Organization-CRO
- Pharmaceuticals
See more in Biomedtracker
Latest on Ora Inc.
HBW Insight
• By Malcolm Spicer
Bausch & Lomb Inc. plans in 2018 to launch the first US OTC ophthalmic solution containing brimonidine tartrate, emphasizing that it differs from the currently available nonprescription ingredient t
Pink Sheet
• By Malcolm Spicer
Bausch & Lomb Inc. plans in 2018 to launch the first US OTC ophthalmic solution containing brimonidine tartrate, emphasizing that it differs from the currently available nonprescription ingredient t
In Vivo
• By Regina Paleski
New At The Helm Company Changes ANDRE , Patrick, PhD To: Pliant Therapeutics Inc. , VP, Biology (April) From: Merck Sharp & Dohme Corp., Principal Scientist Phone: 650-481-6708 BRENNEMAN , Rya